Latest News & Updates
Breaking News
15 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Roche Achieves Phase III Superiority for Divarasib Against Approved KRAS G12C Inhibitors in NSCLC
Roche's divarasib beats sotorasib and adagrasib on PFS and OS in phase III Krascendo 1, triggering imminent FDA and EMA submissions.
Pharma Now Editorial Team
Novartis Gains European Commission Approval for Itvisma in Broad SMA Population
Novartis secures EC approval for Itvisma in SMA patients aged two and older, the first gene replacement therapy cleared for this broad EU population.
Pharma Now Editorial Team
Morepen Begins Commercial Supplies Under Rs. 825 Crore CDMO Contract
Morepen Laboratories activates commercial supply under an Rs. 825 crore CDMO contract, marking a shift from agreement to GMP-compliant production.
Pharma Now Editorial Team
Mankind Pharma Signs AI Drug Discovery Deal with Denovo Sciences to Accelerate Lead Candidate Selection
Mankind Pharma partners with Denovo Sciences to embed AI into early drug discovery, targeting shorter timelines and stronger lead candidates.
Pharma Now Editorial Team
